IOL CHEMICALS & PHARM. | PARNAX LAB | IOL CHEMICALS & PHARM./ PARNAX LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 16.6 | 81.8% | View Chart |
P/BV | x | 1.5 | 2.3 | 65.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PARNAX LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PARNAX LAB Mar-23 |
IOL CHEMICALS & PHARM./ PARNAX LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 170 | 315.9% | |
Low | Rs | 272 | 47 | 577.9% | |
Sales per share (Unadj.) | Rs | 377.6 | 145.9 | 258.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 7.5 | 315.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 13.2 | 239.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 54.1 | 474.7% | |
Shares outstanding (eoy) | m | 58.71 | 11.49 | 511.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.7 | 144.0% | |
Avg P/E ratio | x | 17.1 | 14.4 | 118.2% | |
P/CF ratio (eoy) | x | 12.8 | 8.2 | 155.9% | |
Price / Book Value ratio | x | 1.6 | 2.0 | 78.5% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,246 | 1,905.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 201 | 838.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,676 | 1,322.8% | |
Other income | Rs m | 256 | 8 | 3,317.4% | |
Total revenues | Rs m | 22,427 | 1,684 | 1,331.9% | |
Gross profit | Rs m | 2,257 | 230 | 981.7% | |
Depreciation | Rs m | 462 | 65 | 707.0% | |
Interest | Rs m | 165 | 50 | 332.7% | |
Profit before tax | Rs m | 1,887 | 123 | 1,536.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 36 | 1,357.6% | |
Profit after tax | Rs m | 1,391 | 86 | 1,611.7% | |
Gross profit margin | % | 10.2 | 13.7 | 74.2% | |
Effective tax rate | % | 26.2 | 29.7 | 88.4% | |
Net profit margin | % | 6.3 | 5.2 | 121.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 573 | 1,686.3% | |
Current liabilities | Rs m | 5,025 | 630 | 797.1% | |
Net working cap to sales | % | 20.9 | -3.4 | -613.5% | |
Current ratio | x | 1.9 | 0.9 | 211.6% | |
Inventory Days | Days | 43 | 11 | 407.8% | |
Debtors Days | Days | 8 | 60,742 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 840 | 1,311.5% | |
Share capital | Rs m | 587 | 115 | 511.1% | |
"Free" reserves | Rs m | 14,490 | 507 | 2,859.8% | |
Net worth | Rs m | 15,077 | 622 | 2,425.8% | |
Long term debt | Rs m | 0 | 120 | 0.0% | |
Total assets | Rs m | 20,684 | 1,451 | 1,425.8% | |
Interest coverage | x | 12.5 | 3.5 | 357.8% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.2 | 92.8% | |
Return on assets | % | 7.5 | 9.4 | 80.3% | |
Return on equity | % | 9.2 | 13.9 | 66.4% | |
Return on capital | % | 13.6 | 23.2 | 58.6% | |
Exports to sales | % | 26.7 | 3.9 | 694.6% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 65 | 9,188.3% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 65 | 9,188.3% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 65 | -188.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 209 | 584.7% | |
From Investments | Rs m | -1,200 | -99 | 1,209.2% | |
From Financial Activity | Rs m | -41 | -141 | 29.2% | |
Net Cashflow | Rs m | -18 | -31 | 59.7% |
Indian Promoters | % | 48.2 | 72.3 | 66.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 27.7 | 187.0% | |
Shareholders | 130,003 | 4,496 | 2,891.5% | ||
Pledged promoter(s) holding | % | 0.0 | 9.4 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PARNAX LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | -2.31% | -0.57% |
1-Month | 4.77% | -3.77% | 0.07% |
1-Year | -0.25% | 85.27% | 52.18% |
3-Year CAGR | -13.23% | 81.83% | 14.04% |
5-Year CAGR | 16.12% | 31.17% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PARNAX LAB share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PARNAX LAB the stake stands at 72.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PARNAX LAB.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PARNAX LAB paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PARNAX LAB.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.